Meetings

Medicines Management

This page gives details of any meetings held which will, or did, discuss the matter, and includes links to the relevant Papers, Agendas and Minutes.

Note: Meeting Agenda can change at short notice. Particularly where future meeting dates are indicated more than a week in advance. Please check before planning to attend a Committee Meeting that the item you are interested in has not been moved.

 

 

Meeting: 07/12/2020 - Public Accounts Committee - Fifth Senedd (Item 3)

3 Medicines Management: Letter from the Welsh Government (16 November 2020)

Supporting documents:

Meeting: 21/09/2020 - Public Accounts Committee - Fifth Senedd (Item 2)

2 Medicines Management: Letter from the Welsh Government (28 August 2020)

Supporting documents:

Meeting: 24/02/2020 - Public Accounts Committee - Fifth Senedd (Item 2)

2 Medicines Management: Letter from the Welsh Government (10 February 2020)

Supporting documents:

Meeting: 06/01/2020 - Public Accounts Committee - Fifth Senedd (Item 2)

2 Medicines Management: Letter from the Welsh Government (10 December 2019)

Supporting documents:

Meeting: 29/04/2019 - Public Accounts Committee - Fifth Senedd (Item 2)

2 Medicines Management: Letter from Welsh Government (April 2019)

Supporting documents:

Meeting: 04/02/2019 - Public Accounts Committee - Fifth Senedd (Item 2)

2 Medicines Management: Letter from the Welsh Government (17 January 2019)

Supporting documents:

Meeting: 01/10/2018 - Public Accounts Committee - Fifth Senedd (Item 4)

4 Medicines Management: Letter from the Welsh Government (15 August 2018)

Supporting documents:

Meeting: 11/06/2018 - Public Accounts Committee - Fifth Senedd (Item 3)

3 Medicines Management: Consideration of responses to report recommendations

PAC(5)-16-18 Paper 1 – Welsh Government Response (2 May 2018)

PAC(5)-16-18 Paper 2 – Welsh Government Response (31 May 2018)

PAC(5)-16-18 Paper 3 – Letter from the Auditor General for Wales

 

Supporting documents:

Minutes:

3.1 The Committee noted the responses and it was agreed that the Chair will write to the Welsh Government seeking clarification on a number of the responses to the Committee’s recommendations.

Meeting: 05/03/2018 - Public Accounts Committee - Fifth Senedd (Item 1)

1 Medicines Management: Consideration of the draft report

PAC(5)-07-18 Paper 1 – Draft Report

Supporting documents:

Minutes:

1.1 Members considered and agreed the draft report.

Meeting: 26/02/2018 - Public Accounts Committee - Fifth Senedd (Item 1)

1 Medicines Management: Consideration of draft Report

PAC(5)-06-18 Paper 1 – Draft Report

Supporting documents:

Minutes:

1.1 Members considered the draft report and due to time constraints agreed to return to it at next week’s meeting.

Meeting: 20/11/2017 - Public Accounts Committee - Fifth Senedd (Item 2)

2 Medicines Management: Additional information from the Welsh Government (30 October 2017)

Supporting documents:

Meeting: 13/11/2017 - Public Accounts Committee - Fifth Senedd (Item 2.1)

Medicines Management: Additional information from the Welsh Government (30 October 2017)

Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 5)

Medicines Management: Evidence Session - GP Cluster Group from Aneurin Bevan University Health Board

Dr Alun Edwards - Ty Bryn Surgery, Caerphilly

Dr Alun Walters - Clinical Director, Primary Care & Community Service, Aneurin Bevan University Health Board

Eryl Smeethe - Pharmacist and Neighbourhood Care Networks Lead Torfaen North, Aneurin Bevan University Health Board

Minutes:

5.1 The Committee took evidence from Dr Alun Edwards, Ty Bryn Surgery, Caerphilly; Dr Alun Walters, Clinical Director, Primary Care & Community Service, Aneurin Bevan University Health Board and Eryl Smeethe, Pharmacist and Neighbourhood Care Networks Lead Torfaen North, Aneurin Bevan University Health Board as part of the inquiry on medicines management.

 

 

Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 6)

Medicines Management: Evidence Session - Welsh Government

Research Briefing

 

Andrew Evans – Chief Pharmaceutical Officer, Welsh Government

Professor Chris Jones - Deputy Chief Medical Officer, Welsh Government

Minutes:

6.1 The Committee took evidence from Andrew Evans, Chief Pharmaceutical Officer and Professor Chris Jones, Deputy Chief Medical Officer, Welsh Government as part of the inquiry on medicines management.

6.2 Andrew Evans agreed to send further information on the anticipated roll out date for the MTeD (Medicines Transcribing and e-Discharge) system across Wales.

Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 4)

4 Medicines Management: Evidence Session - GP Cluster Group from Hywel Dda University Health Board

Research Briefing

 

Dr Carwyn Jones - Furnace House Surgery, Carmarthen

Dr Darren Chant - Meddygfa Teifi, Llandysul

Supporting documents:

Minutes:

4.1 The Committee took evidence from Dr Carwyn Jones, Furnace House Surgery, Carmarthen and Dr Darren Chant, Meddygfa Teifi, Llandysul as part of the inquiry on medicines management.

Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 8)

Medicines Management: Consideration of evidence received

Minutes:

8.1 Members considered the evidence received and asked the Clerks to prepare a draft report.

Meeting: 16/10/2017 - Public Accounts Committee - Fifth Senedd (Item 3)

3 Medicines Management: Correspondence

PAC(5)-26-17 Paper 1 – Letter from Royal College of General Practitioners (4 September 2017)

Supporting documents:

Minutes:

3.1 Members considered and noted the letter from the Royal College of General Practitioners.

Meeting: 17/07/2017 - Public Accounts Committee - Fifth Senedd (Item 3)

3 Medicines Management: Reports from Stakeholder Event

PAC(5)-21-17 Paper 1 – Report from visit to Glanrhyd Surgery, Ebbw Vale

PAC(5)-21-17 Paper 3 – Report from visit to Ty Elli Surgery, Llanelli

PAC(5)-21-17 Paper 3 – Report from visit to Stanwell Surgery, Penarth

PAC(5)-21-17 Paper 4 – Additional information from Abertawe Bro Morgannwg University Health Board (ABMUHB)

Supporting documents:

Minutes:

3.1 The papers were noted.

3.2 Members agreed to gather further evidence in the autumn term.

 

Meeting: 19/06/2017 - Public Accounts Committee - Fifth Senedd (Item 4)

4 Medicines Management: Evidence Session 3

PAC(5)-17-17 Paper 1 – Paper from Cwm Taf University Health Board

PAC(5)-17-17 Paper 2 – Paper from Powys Teaching Health Board

PAC(5)-17-17 Paper 3 – Paper from Abertawe Bro Morgannwg University Health Board

 

Allison Williams – Chief Executive, Cwm Taf University Health Board

Suzanne Scott-Thomas, Chief Pharmacist, Cwm Taf University Health Board

Professor Rory Farrelly – Acting Chief Operating Officer/Deputy Chief Executive & Director of Nursing and Patient Evidence, Abertawe Bro Morgannwg University Health Board

Judith Vincent – Clinical Director for Pharmacy and Medicines Management, Abertawe Bro Morgannwg University Health Board

Carol Shillabeer – Chief Executive, Powys Teaching Health Board

Karen Gully – Medical Director, Powys Teaching Health Board

Supporting documents:

Minutes:

4.1 The Committee took evidence from Allison Williams, Chief Executive, Cwm Taf University Health Board; Suzanne Scott-Thomas, Chief Pharmacist, Cwm Taf University Health Board; Professor Rory Farrelly, Acting Chief Operating Officer/Deputy Chief Executive & Director of Nursing and Patient Evidence, Abertawe Bro Morgannwg University Health Board; Judith Vincent, Clinical Director for Pharmacy and Medicines Management, Abertawe Bro Morgannwg University Health Board; Carol Shillabeer, Chief Executive, Powys Teaching Health Board and Karen Gully, Medical Director, Powys Teaching Health Board as part of their inquiry into medicines management.

4.2 Judith Vincent agreed to provide additional information on the work Professor Routledge is facilitating with experts on medicines related admissions regarding patient safety.

Meeting: 19/06/2017 - Public Accounts Committee - Fifth Senedd (Item 3)

3 Medicines Management: Evidence Session 2

Research Briefing

 

Judy Henley – Director of Contractor Services, Community Pharmacy Wales

Mark Griffiths - Chair of Community Pharmacy Wales

Mair Davies - Director, Royal Pharmaceutical Society Wales

Cheryl Way – RPS Board Member (Principal Pharmacist, Cardiff and Vale University Health Board and National Pharmacy and Medicines Management Lead, NHS Wales Informatics Service)

Supporting documents:

Minutes:

3.1 The Committee took evidence from Judy Henley, Director of Contractor Services, Community Pharmacy Wales; Mark Griffiths, Chair of Community Pharmacy Wales; Elen Jones, Practice and Policy lead for Royal Pharmaceutical Society Wales and Cheryl Way, RPS Board Member (Principal Pharmacist, Cardiff and Vale University Health Board and National Pharmacy and Medicines Management Lead, NHS Wales Informatics Service) as part of their inquiry into medicines management.

3.2 The Committee noted that Elen Jones had attended in place of Mair Davies, Director of RPS Wales due to sickness.

Meeting: 19/06/2017 - Public Accounts Committee - Fifth Senedd (Item 6)

Medicines Management: Consideration of evidence received

Minutes:

6.1 Members considered the evidence received.

Meeting: 08/05/2017 - Public Accounts Committee - Fifth Senedd (Item 2)

2 Medicines Management: Additional information from the Welsh Government (28 April 2017)

Supporting documents:

Meeting: 27/03/2017 - Public Accounts Committee - Fifth Senedd (Item 2)

2 Medicines Management: Letter from Boots (9 March 2017)

Supporting documents:

Meeting: 06/03/2017 - Public Accounts Committee - Fifth Senedd (Item 3)

3 Medicines Management: Evidence Session with the Welsh Government

Research Briefing

PAC(5)-08-17 Paper 1 – Welsh Government’s response to the Auditor General for Wales’ Report  on Managing Medicines in Primary and Secondary Care

 

Dr Andrew Goodall - Director General/NHS Chief Executive

Andrew Evans - Chief Pharmaceutical Officer, Welsh Government

Jean White - Chief Nursing Officer, Welsh Government

Alan Brace - Director of Finance, Welsh Government

Supporting documents:

Minutes:

3.1 The Committee took evidence from Dr Andrew Goodall, Director General/NHS Chief Executive; Andrew Evans, Chief Pharmaceutical Officer; Professor Jean White, Chief Nursing Officer; and Alan Brace, Director of Finance, Welsh Government as part of its inquiry into medicines management.

3.2 Dr Goodall agreed to undertake an evaluation on the numbers of wards using automatic medicine vending of medicines and will also look to clarify tensions in the system at the same time.

3.3 The Committee agreed to take further evidence from health boards in the summer term.

Meeting: 06/03/2017 - Public Accounts Committee - Fifth Senedd (Item 5)

Medicines Management: Consideration of evidence received

Minutes:

5.1 Members considered the evidence received.

Meeting: 30/01/2017 - Public Accounts Committee - Fifth Senedd (Item 8)

8 Medicines Management: Auditor General for Wales' Report

Research Briefing

 

PAC(5)-04-17 Paper 8 – Auditor General for Wales’s report

PAC(5)-04-17 Paper 9 – Welsh Government Response to Auditor General for Wales’s report

Supporting documents:

Minutes:

8.1 The Committee received a briefing on the Auditor General for Wales’ report on his recent report on medicines management.

8.2 The Committee agreed to hold an evidence session with the Welsh Government on this issue in spring 2017.

 

 

Topics

Helpful Links

Related